.png)
Lupin Limited, a global pharmaceutical company, has received the Establishment Inspection Report (EIR) of the Lupin Pithampur Unit-3 plant in Madhya Pradesh. This report is a follow-up to a successful inspection conducted between July 7 and...
Cupid Ltd., a health and wellness products leading manufacturer, revealed that it foresees producing annual revenue of Rs 115 crore from the South African market, after its achievement of securing the largest allocation
Sun Pharmaceutical Industries Ltd has in Q2 of 2026 financial year, to a large extent, sold innovative medicines in the US market than generics. The achievement was a result of a robust market demand for Ilumya
The World Health Organization (WHO) and Bayer AG have renewed their two-decade collaboration to combat neglected tropical diseases (NTDs), extending the partnership through 2025–2030...
Zydus Lifesciences has been able to accomplish a pre-Approval Inspection PAI successfully without any observation by the US Food and Drug Administration (USFDA) at its SEZ II manufacturing facility in Ahmedabad.
Granules India Ltd. announced that the USFDA has issued an Establishment Inspection Report (EIR) for Granules Pharmaceuticals, Inc., a wholly-owned subsidiary of Granules India Ltd. in Chantilly, Virginia.
Mankind Pharma said it has secured a 'B' ESG rating from MSCI ESG Ratings and Research Private Limited in a key milestone that validates the company's journey toward better sustainability and governance standards...
In response to the ongoing ‘Nasha Mukti Bharat Abhiyan’ and under the clear directives of FDA Commissioner Manoj Kumar, the drug control administration (DCA) in Haryana conducted a significant and coordinated inspection operation in Sirsa district on
The World Health Organization (WHO) has published new guidelines for nations on how to mitigate the short-term and long-term consequences of abrupt and drastic cuts to external financing, which are interfering with the provision of critical health se
Cipla Ltd. had signed binding agreements to purchase the entire shareholding of Inzpera Healthscience Pvt. Ltd. for around Rs 110.65 crore.
.jpg)
, CDSCO.jpg)